702 related articles for article (PubMed ID: 23810175)
21. Extent of lymph node removal during esophageal cancer surgery and survival.
van der Schaaf M; Johar A; Wijnhoven B; Lagergren P; Lagergren J
J Natl Cancer Inst; 2015 May; 107(5):. PubMed ID: 25748792
[TBL] [Abstract][Full Text] [Related]
22. A strategy for supraclavicular lymph node dissection using recurrent laryngeal nerve lymph node status in thoracic esophageal squamous cell carcinoma.
Taniyama Y; Nakamura T; Mitamura A; Teshima J; Katsura K; Abe S; Nakano T; Kamei T; Miyata G; Ouchi N
Ann Thorac Surg; 2013 Jun; 95(6):1930-7. PubMed ID: 23642437
[TBL] [Abstract][Full Text] [Related]
23. [Regulations and lymphadenectomy strategy of mediastinal and upper abdominal lymph node metastasis in thoracic esophageal carcinoma].
Xue HC; Wu CR; Zhang ZB; Zhu ZH; Ma ZK; Gao J
Ai Zheng; 2007 Sep; 26(9):1020-4. PubMed ID: 17927865
[TBL] [Abstract][Full Text] [Related]
24. [Recurrence patterns of esophageal cancer after Ivor-Lewis esophagectomy--a report of 196 cases].
Chen G; Wang Z; Liu XY; Liu FY
Ai Zheng; 2006 Jan; 25(1):96-9. PubMed ID: 16405760
[TBL] [Abstract][Full Text] [Related]
25. Elective, therapeutic, and delayed lymph node dissection for malignant melanoma of the head and neck: analysis of 1444 patients from 1970 to 1998.
Fisher SR
Laryngoscope; 2002 Jan; 112(1):99-110. PubMed ID: 11802046
[TBL] [Abstract][Full Text] [Related]
26. [Lymph node dissection for T1 esophageal cancer].
Mitomi T; Makuucuhi H
Nihon Geka Gakkai Zasshi; 1997 Sep; 98(9):727-32. PubMed ID: 9370129
[TBL] [Abstract][Full Text] [Related]
27. [Prognosis of malignant melanoma following dissection regional lymph node metastases].
Sprakel B; Stenschke F; Unnewehr M; Ladas A; Senninger N
Chirurg; 2003 Jan; 74(1):55-60. PubMed ID: 12552406
[TBL] [Abstract][Full Text] [Related]
28. Outcome and treatment strategy for mid- and lower-thoracic esophageal cancer recurring locally in the lymph nodes of the neck.
Motoyama S; Kitamura M; Saito R; Maruyama K; Okuyama M; Ogawa J
World J Surg; 2006 Feb; 30(2):191-8. PubMed ID: 16425071
[TBL] [Abstract][Full Text] [Related]
29. Total number of resected lymph nodes predicts survival in esophageal cancer.
Altorki NK; Zhou XK; Stiles B; Port JL; Paul S; Lee PC; Mazumdar M
Ann Surg; 2008 Aug; 248(2):221-6. PubMed ID: 18650631
[TBL] [Abstract][Full Text] [Related]
30. Prediction of lymph node status in superficial esophageal carcinoma.
Ancona E; Rampado S; Cassaro M; Battaglia G; Ruol A; Castoro C; Portale G; Cavallin F; Rugge M
Ann Surg Oncol; 2008 Nov; 15(11):3278-88. PubMed ID: 18726651
[TBL] [Abstract][Full Text] [Related]
31. Risk factors that influence early death due to cancer recurrence after extended radical esophagectomy with three-field lymph node dissection.
Kosugi S; Kanda T; Yajima K; Ishikawa T; Hatakeyama K
Ann Surg Oncol; 2011 Oct; 18(10):2961-7. PubMed ID: 21499809
[TBL] [Abstract][Full Text] [Related]
32. [Comparison of the results of lymph node dissection via left versus right thoracotomy].
Mao YS; He J; Dong JS; Cheng GY; Sun KL; Liu XY; Fang DK; Li J; Wang YG
Zhonghua Zhong Liu Za Zhi; 2012 Apr; 34(4):296-300. PubMed ID: 22781044
[TBL] [Abstract][Full Text] [Related]
33. Clinicopathologic features of superficial esophageal cancer: results of consecutive 100 patients.
Tachibana M; Hirahara N; Kinugasa S; Yoshimura H
Ann Surg Oncol; 2008 Jan; 15(1):104-16. PubMed ID: 17891442
[TBL] [Abstract][Full Text] [Related]
34. Predictors of long-term survival after resection of esophageal carcinoma with nonregional nodal metastases.
Lee PC; Port JL; Paul S; Stiles BM; Altorki NK
Ann Thorac Surg; 2009 Jul; 88(1):186-92; discussion 192-3. PubMed ID: 19559222
[TBL] [Abstract][Full Text] [Related]
35. Do tumours located in the left lower lobe have worse outcomes in lymph node-positive non-small cell lung cancer than tumours in other lobes?
Kudo Y; Saji H; Shimada Y; Nomura M; Usuda J; Kajiwara N; Ohira T; Ikeda N
Eur J Cardiothorac Surg; 2012 Sep; 42(3):414-9. PubMed ID: 22398463
[TBL] [Abstract][Full Text] [Related]
36. Two-step three-field lymph node dissection is beneficial for thoracic esophageal carcinoma.
Noguchi T; Wada S; Takeno S; Hashimoto T; Moriyama H; Uchida Y
Dis Esophagus; 2004; 17(1):27-31. PubMed ID: 15209737
[TBL] [Abstract][Full Text] [Related]
37. A second malignancy is the major cause of death among thoracic squamous cell esophageal cancer patients negative for lymph node involvement.
Sato Y; Motoyama S; Maruyama K; Okuyama M; Ogawa J
J Am Coll Surg; 2005 Aug; 201(2):188-93. PubMed ID: 16038814
[TBL] [Abstract][Full Text] [Related]
38. Clinical outcomes and prognosis after thoracoscopic esophagectomy with two-field lymph node dissection for lower thoracic esophageal cancer.
Takemura M; Hori T; Fujiwara Y
Anticancer Res; 2013 Feb; 33(2):601-8. PubMed ID: 23393354
[TBL] [Abstract][Full Text] [Related]
39. Pattern of lymph node metastases of esophageal squamous cell carcinoma based on the anatomical lymphatic drainage system.
Tachimori Y; Nagai Y; Kanamori N; Hokamura N; Igaki H
Dis Esophagus; 2011 Jan; 24(1):33-8. PubMed ID: 20626450
[TBL] [Abstract][Full Text] [Related]
40. Lymph node ratio is an independent prognostic factor in gastric cancer after curative resection (R0) regardless of the examined number of lymph nodes.
Alatengbaolide ; Lin D; Li Y; Xu H; Chen J; Wang B; Liu C; Lu P
Am J Clin Oncol; 2013 Aug; 36(4):325-30. PubMed ID: 22547011
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]